Eikmans M, van der Keur C, Anholts J, Drabbels J, van Beelen E, de Sousa Lopes S, et al. Primary Trophoblast Cultures: Characterization of HLA Profiles and Immune Cell Interactions. Front Immunol. 2022;13:814019 pubmed publisher

Kosti P, Opzoomer J, Larios Martinez K, Henley Smith R, Scudamore C, Okesola M, et al. Hypoxia-sensing CAR T cells provide safety and efficacy in treating solid tumors. Cell Rep Med. 2021;2:100227 pubmed publisher

Marrocco I, Romaniello D, Vaknin I, Drago García D, Oren R, Uribe M, et al. Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models. EMBO Mol Med. 2021;13:e13144 pubmed publisher

Tiago M, Capparelli C, Erkes D, Purwin T, Heilman S, Berger A, et al. Targeting BRD/BET proteins inhibits adaptive kinome upregulation and enhances the effects of BRAF/MEK inhibitors in melanoma. Br J Cancer. 2020;122:789-800 pubmed publisher

Kumai T, Ohkuri T, Nagato T, Matsuda Y, Oikawa K, Aoki N, et al. Targeting HER-3 to elicit antitumor helper T cells against head and neck squamous cell carcinoma. Sci Rep. 2015;5:16280 pubmed publisher

Zabransky D, Yankaskas C, Cochran R, Wong H, Croessmann S, Chu D, et al. HER2 missense mutations have distinct effects on oncogenic signaling and migration. Proc Natl Acad Sci U S A. 2015;112:E6205-14 pubmed publisher